Prognostic factors of COVID‐19: an umbrella review endorsed by the International Society for Pharmacoepidemiology

G Sarri, W Liu, L Zabotka, A Freitag… - Clinical …, 2023 - Wiley Online Library
During the coronavirus disease 2019 (COVID‐19) pandemic, the urgency for updated
evidence to inform public health and clinical care placed systematic literature reviews …

[HTML][HTML] Glycemic dysregulation, inflammation and disease outcomes in patients hospitalized with COVID-19: beyond diabetes and obesity

A Liontos, D Biros, A Kavakli, R Matzaras, I Tsiakas… - Viruses, 2023 - mdpi.com
Introduction: During the COVID-19 pandemic, diabetes mellitus (DM) and obesity were
associated with high rates of morbidity and mortality. The aim of this study was to investigate …

[HTML][HTML] Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients

E Tekle, Y Gelaw, M Dagnew, A Gelaw, M Negash… - PLoS …, 2022 - journals.plos.org
Background COVID-19 is a viral disease caused by a new strain of corona virus. Currently,
prognosis and risk stratification of COVID-19 patients is done by the disease's clinical …

[HTML][HTML] Serum SARS-CoV-2 antigens for the determination of COVID-19 severity

J Favresse, JL Bayart, C David, C Gillot, G Wieërs… - Viruses, 2022 - mdpi.com
The diagnostic of SARS-CoV-2 infection relies on reverse transcriptase polymerase chain
reactions (RT-PCRs) performed on nasopharyngeal (NP) swabs. Nevertheless, false …

Repurposing drugs targeting epidemic viruses

V Namasivayam, S Palaniappan, M Vanangamudi - Drug Discovery Today, 2022 - Elsevier
Highlights•Drug repurposing is a powerful strategy for discovering new indications for drugs
that are used in various clinical applications.•The repurposing drugs approach reduces the …

[HTML][HTML] When outcomes diverge: age and cardiovascular risk as determinants of mortality and ICU admission in COVID-19

M Ranucci, G Parati, U Di Dedda, M Bussotti… - Journal of Clinical …, 2022 - mdpi.com
Background: Hospital mortality and admission to the Intensive Care Unit (ICU) are markers
of disease severity in COVID-19 patients. Cardiovascular co-morbidities are one of the main …

[HTML][HTML] Predicting potentially fatal COVID-19 disease in pregnant patients using the neutrophil-to-lymphocyte ratio (NLR)

D Supák, B Mészáros, B Turi, Z Herold, Z Kukor… - Journal of Clinical …, 2023 - mdpi.com
Objective: To evaluate the neutrophil-to-lymphocyte ratio (NLR) values' possible predictive
role in fatal and severe cases of COVID-19 disease in pregnant women. Design and data …

[HTML][HTML] Predictors of death among severe COVID-19 patients admitted in Hawassa City, Sidama, Southern Ethiopia: Unmatched case-control study

S Misganaw, B Eshetu, A Adane, T Solomon - Plos one, 2023 - journals.plos.org
Introduction Since COVID-19 was announced as a worldwide pandemic, the world has been
struggling with this disease. In Ethiopia, there is some information on the epidemiological …

[HTML][HTML] Causal relationship between particulate matter 2.5 and infectious diseases: A two-sample Mendelian randomization study

Y Zeng, K Pang, S Cao, G Lin, J Tang - Heliyon, 2024 - cell.com
Background Previous observational studies suggested a correlation between particulate
matter 2.5 (PM 2.5) and infectious diseases, but causality remained uncertain. This study …

[HTML][HTML] Admission predictors of mortality in hospitalized COVID-19 patients—a Serbian cohort study

M Poskurica, Đ Stevanović, V Zdravković… - Journal of Clinical …, 2022 - mdpi.com
Background: Early prediction of COVID-19 patients' mortality risk may be beneficial in
adequate triage and risk assessment. Therefore, we aimed to single out the independent …